Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Journal of Biopharmaceutical Statistics
|
December 14, 2004
Modeling missingness for time-to-event data: a case study in osteoporosis
Beat Neuenschwander, Michael Branson
Biometrics
|
July 1, 2011
Discussion of the article by Trippa, Rosner, and Müller on Bayesian enrichment strategies for randomized discontinuation trials
Heinz Schmidli, Beat Neuenschwander
Statistics in Medicine
|
January 28, 2020
Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint
Satrajit Roychoudhury, Beat Neuenschwander
Clinical Trials (London, England)
|
September 12, 2018
Beyond p-values: A phase II dual-criterion design with statistical significance and clinical relevance
Satrajit Roychoudhury, Nicolas Scheuer, Beat Neuenschwander
Statistical Methods in Medical Research
|
January 6, 2012
The network meta-analytic-predictive approach to non-inferiority trials
Heinz Schmidli, Simon Wandel, Beat Neuenschwander
Statistics in Medicine
|
March 18, 2008
Critical aspects of the Bayesian approach to phase I cancer trials
Beat Neuenschwander, Michael Branson, Thomas Gsponer
Statistics in Medicine
|
September 8, 2009
A note on the power prior
Beat Neuenschwander, Michael Branson, David J Spiegelhalter
Research Synthesis Methods
|
July 1, 2016
Meta-analysis of few small studies in orphan diseases
Tim Friede, Christian Röver, Simon Wandel, et al.
Journal of Biopharmaceutical Statistics
|
April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariates
Stuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Biometrical Journal. Biometrische Zeitschrift
|
October 19, 2016
Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases
Tim Friede, Christian Röver, Simon Wandel, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Journal of Biopharmaceutical Statistics
|
December 14, 2004
Modeling missingness for time-to-event data: a case study in osteoporosis
Beat Neuenschwander, Michael Branson
Biometrics
|
July 1, 2011
Discussion of the article by Trippa, Rosner, and Müller on Bayesian enrichment strategies for randomized discontinuation trials
Heinz Schmidli, Beat Neuenschwander
Statistics in Medicine
|
January 28, 2020
Bayesian leveraging of historical control data for a clinical trial with time-to-event endpoint
Satrajit Roychoudhury, Beat Neuenschwander
Clinical Trials (London, England)
|
September 12, 2018
Beyond p-values: A phase II dual-criterion design with statistical significance and clinical relevance
Satrajit Roychoudhury, Nicolas Scheuer, Beat Neuenschwander
Statistical Methods in Medical Research
|
January 6, 2012
The network meta-analytic-predictive approach to non-inferiority trials
Heinz Schmidli, Simon Wandel, Beat Neuenschwander
Statistics in Medicine
|
March 18, 2008
Critical aspects of the Bayesian approach to phase I cancer trials
Beat Neuenschwander, Michael Branson, Thomas Gsponer
Statistics in Medicine
|
September 8, 2009
A note on the power prior
Beat Neuenschwander, Michael Branson, David J Spiegelhalter
Research Synthesis Methods
|
July 1, 2016
Meta-analysis of few small studies in orphan diseases
Tim Friede, Christian Röver, Simon Wandel, et al.
Journal of Biopharmaceutical Statistics
|
April 23, 2009
A Bayesian case study in oncology Phase I combination dose-finding using logistic regression with covariates
Stuart Bailey, Beat Neuenschwander, Glen Laird, et al.
Biometrical Journal. Biometrische Zeitschrift
|
October 19, 2016
Meta-analysis of two studies in the presence of heterogeneity with applications in rare diseases
Tim Friede, Christian Röver, Simon Wandel, et al.
Page
of 3